Defining Insights.
Insights
Medical affairs
Medical information
Metrics
Pharmaceutical industry
phactMI
Journal
Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
23
03
2023
accepted:
13
06
2023
pubmed:
5
7
2023
medline:
5
7
2023
entrez:
5
7
2023
Statut:
ppublish
Résumé
Insights, when acted upon, can result in positive changes to the business, for HCPs, and ultimately for patients. Medical Information, as a customer facing function, is one of the groups that generate insights. Data and insights across different functions of an organization need to be compiled to provide a comprehensive view. The purpose of this paper is to develop a shared definition of insights and to provide a working guidance for the insight process. Two surveys were conducted of the phactMI membership first to establish a shared definition of insights and then to benchmark current insight process. From this data and the shared experience of the working group a proposed guidance was developed. The developed definition of an insight is "An insight is the deeper understanding of the why behind trends of information that lead us to determine if an action is warranted". For the most robust outcomes, insight identification needs to be a cross functional activity. The proposed structured approach can be leveraged and customized for any organization and include the following five steps: INvestigate, Scrutinize, Identify, Take Action, and Enlighten (INSITE). The INSITE process provides a simple framework that should become routine for all Medical Information colleagues who are leading the work around insights. The process should be shared across all functions that participate in the insight generation process. This is another area where Medical Information can demonstrate leadership and highlight their value to the organization.
Sections du résumé
BACKGROUND
BACKGROUND
Insights, when acted upon, can result in positive changes to the business, for HCPs, and ultimately for patients. Medical Information, as a customer facing function, is one of the groups that generate insights. Data and insights across different functions of an organization need to be compiled to provide a comprehensive view. The purpose of this paper is to develop a shared definition of insights and to provide a working guidance for the insight process.
METHODS
METHODS
Two surveys were conducted of the phactMI membership first to establish a shared definition of insights and then to benchmark current insight process. From this data and the shared experience of the working group a proposed guidance was developed.
RESULTS
RESULTS
The developed definition of an insight is "An insight is the deeper understanding of the why behind trends of information that lead us to determine if an action is warranted". For the most robust outcomes, insight identification needs to be a cross functional activity. The proposed structured approach can be leveraged and customized for any organization and include the following five steps: INvestigate, Scrutinize, Identify, Take Action, and Enlighten (INSITE).
CONCLUSION
CONCLUSIONS
The INSITE process provides a simple framework that should become routine for all Medical Information colleagues who are leading the work around insights. The process should be shared across all functions that participate in the insight generation process. This is another area where Medical Information can demonstrate leadership and highlight their value to the organization.
Identifiants
pubmed: 37405679
doi: 10.1007/s43441-023-00554-w
pii: 10.1007/s43441-023-00554-w
pmc: PMC10579153
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1229-1237Informations de copyright
© 2023. The Author(s).
Références
Guidance for Industry - Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices - DRAFT GUIDANCE. US Food and Drug Administration. (2011). https :// www.fda.gov/regulatory-information/search-fda-guidance-documents/responding-unsolicited-requests-label-information-about-prescription-drugs-and-medical-devices . Accessed 13 March 2023
Virzi LA, Dahl P, Hill L, et al. The value and strategic implementation of insights management. Medical Affairs Professional Society. (2023). https://medicalaffairs.org/value-and-strategic-implementation-of-insights-management/ Accessed 13 March 2023.
Accelerating customer- centric innovation in Med tech. McKinsey and company (2023) https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-customer-centric-innovation-in-medtech . Accessed 13 March 2023
Evers M, Hartman JP, Pradell C, et al. How pharma manufacturers can enhance their medical information teams. McKinsey and company (2018) https://www.mckinsey.com/industries/life-sciences/our-insights/how-pharma-manufacturers-can-enhance-their-medical-information-teams .
Data versus information versus insight. VOCII period. https://voccii.com/data-information-insight . Accessed 13 March 2023
A guide to transforming insights into business value. Within3 (2022) https://medicalaffairs.org/wp-content/uploads/2022/08/W3_WhitePaper_BestPractice_TransformingInsights_BusinessValue_MedAffairs.pdf Accessed 13 March 2023